J Steroid Biochem 1987; 27: 487–92.
11. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancerGut 2013; 62: 6 933–947
12. Akiyoshi T, Ueno M, Fukunaga Y, et al.Effect of body mass index on short-term outcomes of patients undergoing laparoscopic resection for colorectal cancer: a single institution experience in Japan.Surg Laparosc Endosc Percutan Tech 2011; 21: 409–14.
13. Singh A, Muthukumarasamy G, Pawa N, et al.Laparoscopic colorectal cancer surgery in obese patients.Colorectal Dis 2011; 13: 878–83.
14. Simkens LH, Koopman M, Mol L, et al.Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy.Eur J Cancer 2011; 47: 2560–7.
15. Giovannucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review.Am J Clin Nutr 2007;86: s 836–42.
16. LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer.Cancer Lett 2003; 195: 127–37.
17. Donohoe CL, Doyle SL, Reynolds JV.Visceral adiposity, insulin resistance and cancer risk.Diabetol Metab Syndr 2011; 3: 12.
18. Pearson JR, Gill CI, Rowland IR. Diet, fecal water, and colon cancer– development of a biomarker.Nutr Rev 2009; 67: 509–26.
19. Nagengast FM, Grubben MJ, van Munster IP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer. 1995 Jul-Aug; 31A(7–8): 1067–70.
20. Everson GT, McKinley C, Kern F Jr. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism.J Clin Invest 1991; 87: 237–46.
21. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer.Gastroenterology 2011; 140: 1807–16.
22. Cani PD, Osto M, Geurts L, et al. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012; 3: 279–88.
23. DiBaise JK, Zhang H, Crowell MD, et al. Gut microbiota and its possible relationship with obesity.Mayo Clin Proc 2008; 83: 460–9.
25. Ildaphonse G, George PS, Mathew A., Obesity and kidney cancer risk in men: a meta-analysis. Asian Pac J Cancer Prev. 2009 Apr-Jun; 10(2): 279–86.
26. Bergström A>1, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A. Obesity and renal cell cancer – a quantitative review.Br J Cancer. 2001 Sep 28;85(7):984-90.
27. Gui-Ming Zhang, Yao Zhu and Ding-Wei Ye. Metabolic syndrome and renal cell carcinoma.World J Surg Oncol. 2014 Jul 29; 12(1): 236.
28. Häggström C, Rapp K, Stocks T, Manjer J, Bjørge T, Ulmer H, Engeland A, Almqvist M, Concin H, Selmer R, Ljungberg B, Tretli S, Nagel G, Hallmans G, Jonsson H, Stattin P. Metabolic factors associated with risk of renal cell carcinoma. PLoS One. 2013;8(2):e57475.
29. Park J, Morley TS, Kim M, Clegg DJ, Scherer PE, Obesity and cancer-mechanisms underlying tumour progression and recurrence.Nat Rev Endocrinol. 2014 Aug; 10(8): 455–65.
30. Otunctemur A, Ozbek E, Sahin S, Dursun M, Besiroglu H, Koklu I, Erkoc M, Danis E, Bozkurt M, Gurbuz A. Diabetes mellitus as a risk factor for high grade renal cell carcinoma.Asian Pac J Cancer Prev. 2014; 15(9): 3993–6.
31. De Pergola G, Silvestris F. Obesity as a major risk factor for cancer.J Obes. 2013; 2013: 291546. doi: 10.1155/2013/291546. Epub 2013 Aug 29.
32. Bollschweiler E, Wolfgarten E, Gutschow C, et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001; 92: 549–5.
33. 4. Whiteman DC, Sadeghi S, Pandeya N, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008; 57: 173–80.
34. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143: 199–211
35. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis.Cancer Epidemiol Biomarkers Prev 2006; 15: 872–8
36. Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 2011; 8: 340–7.
